Litcius/Paper detail

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults

Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Yuan Lin, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Shi Jin, Jincun Zhao, Zhen Huang, Cheng‐Feng Qin

2022Cell Research26 citationsDOIOpen Access PDF

Topics & Concepts

ImmunogenicityBiologyHeterologousVirologyBoosting (machine learning)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakComputational biologyImmunologyGeneticsInfectious disease (medical specialty)Immune systemGeneDiseaseOutbreakInternal medicineMedicineArtificial intelligenceComputer scienceSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchSARS-CoV-2 detection and testing